Stance Capital LLC Viatris Inc Transaction History

Stance Capital LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 22, 2025	SELL	$7.26 - $9.12 $572,218 - $718,820	-78,818 Reduced 25.69%	227,939 $2.04 Billion
Q1 2025 May 16, 2025	BUY	$8.68 - $12.42 $1.65 Million - $2.37 Million	190,561 Added 164.0%	306,757 $2.67 Billion
Q4 2024 Apr 14, 2025	BUY	$11.32 - $13.37 $1.32 Million - $1.55 Million	116,196 New	116,196 $1.45 Billion

1,132

967M

7.74M

2.47M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $13B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Stance Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Stance Capital LLC with notifications on news.